Notice of Informational Webinar for Cancer Prevention Clinical Trials Network (CP-CTNet): RFA-CA-24-024 and RFA-CA-24-025
Notice Number:
NOT-CA-24-095

Key Dates

Release Date:
August 15, 2024

Related Announcements

  • August 12, 2024 - Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required). See RFA-CA-24-024
  • August 12, 2024 - Cancer Prevention Clinical Trials Network (CP-CTNet): Data Management, Auditing, and Statistical Center (DMASC) (UG1 Clinical Trial Required). See RFA-CA-24-025

Issued by

National Cancer Institute (NCI)

Purpose

The National Cancer Institute (NCI) will hold a public pre-application webinar for NCI’s Division of Cancer Prevention notices of funding opportunity (NOFOs) entitled “Cancer Prevention Clinical Trials Network (CP-CTNet)”.

The RFA “Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required) " was published August 12, 2024.

The RFA “Cancer Prevention Clinical Trials Network (CP-CTNet): Data Management, Auditing, and Statistical Center (DMASC) (UG1 Clinical Trial Required) " was published August 12, 2024.

The pre-application webinars, to be held on Tuesday, August 27, 2024, from 1:00 pm – 2:00pm ET (RFA-CA-24-024) and from 2:30-3:30pm ET (RFA-CA-24-025), will provide overall information about the NOFOs and address any special requirements for applications submitted to these two funding opportunities. The goal of CP-CTNet is to perform early phase cancer prevention clinical trials to evaluate the biologic effects of preventive agents and interventions and to determine clinically relevant correlates in order to advance their development for cancer prevention. CP-CTNet consists of two components that will be awarded through two NOFO announcements:

  • CP-CTNet Sites, whose role will be to design, perform and report the results of early phase (phase 0-II) cancer prevention clinical trials (RFA-CA-24-024).  
  • Data Management, Auditing, and Statistical Center (DMASC), which will provide centralized data management, statistical support, and auditing of clinical trials data, as well as administrative support for all CP-CTNet recipients (RFA-CA-24-025).

The two webinars relate to the two components of CP-CTNet.

Each webinar will conclude with an open question and answer session.

Potential applicants are encouraged to submit their questions in advance to [email protected].

Note: Questions about the scope of each NOFO will be addressed during the webinar; however, questions about investigators' specific study aims will not be addressed in the webinar and can be directed to the point of contact for this NOFO.
 

Separate registration is required for each webinar.

Following the webinars, NCI DCP will link to recordings on https://prevention.cancer.gov/cp-ctnet 

Inquiries

Please direct all inquiries to: